4.6 Review

Safety of antidiabetes medications: An update

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 98, Issue 2, Pages 185-195

Publisher

WILEY
DOI: 10.1002/cpt.125

Keywords

-

Funding

  1. AstraZeneca
  2. Bristol-Myers Squibb
  3. Amylin Pharmaceuticals

Ask authors/readers for more resources

Adverse iatrogenic effects of especial relevance for antidiabetes medications include hypoglycemic episodes, major adverse cardiovascular (CV) events, cancer, bone fractures, pancreatic effects, genital/urinary tract infections, and weight gain. Here, recent clinical studies addressing safety profiles of antidiabetes medications are reviewed. On balance, new prospective and population-based studies continue to indicate that the benefits of improved glucose control outweigh the risks associated with antidiabetes medications in most patients with type 2 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available